Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 15, 2025, Lonza (LONN.SW) has a market cap of $47.74 billion USD. According to our data, Lonza is ranked No.408 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 15, 2025 | $47.74 B |
1.23%
|
| Dec 30, 2024 | $47.16 B |
52.64%
|
| Dec 29, 2023 | $30.89 B |
-21.46%
|
| Dec 30, 2022 | $39.34 B |
-40.18%
|
| Dec 30, 2021 | $65.76 B |
34.60%
|
| Dec 30, 2020 | $48.86 B |
62.08%
|
| Dec 30, 2019 | $30.14 B |
39.91%
|
| Dec 28, 2018 | $21.54 B |
-2.22%
|
| Dec 29, 2017 | $22.03 B |
61.23%
|
| Dec 30, 2016 | $13.67 B |
9.78%
|
| Dec 30, 2015 | $12.45 B |
48.25%
|
| Dec 30, 2014 | $8.40 B |
36.05%
|
| Dec 30, 2013 | $6.17 B |
77.71%
|
| Dec 28, 2012 | $3.47 B |
-6.78%
|
| Dec 30, 2011 | $3.73 B |
-23.69%
|
| Dec 30, 2010 | $4.88 B |
4.80%
|
| Dec 31, 2009 | $4.66 B |
-23.91%
|
| Dec 31, 2008 | $6.12 B |
-28.05%
|
| Dec 31, 2007 | $8.51 B |
32.21%
|
| Dec 29, 2006 | $6.43 B |
32.92%
|
| Dec 30, 2005 | $4.84 B |
27.81%
|
| Dec 31, 2004 | $3.79 B |
-8.16%
|
| Dec 31, 2003 | $4.12 B |
-13.20%
|
| Dec 31, 2002 | $4.75 B |
-6.59%
|
| Dec 31, 2001 | $5.09 B |
36.12%
|
| Dec 29, 2000 | $3.74 B |
9.94%
|
| Dec 31, 1999 | $3.40 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Thermo Fisher Scientific
TMO
|
$166.47 B |
0.002 M
|
USA
|
 Danaher
DHR
|
$135.88 B |
0.003 M
|
USA
|
 Catalent
CTLT
|
$11.52 B |
0.000 M
|
USA
|
 Charles River Laboratories
CRL
|
$5.20 B |
-0.000 M
|
USA
|
 Bio-Rad Laboratories
BIO
|
$6.82 B |
1.204 B
|
USA
|
 Agilent Technologies
A
|
$29.40 B |
-0.001 M
|
USA
|
 Merck KGaA
MRK.DE
|
$58.46 B |
41.080 B
|
Germany
|
 Samsung Biologics
207940.KS
|
$51.32 B |
-0.149 B
|
S. Korea
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
| Market Cap | = | LONN.SW Stock Price | * | LONN.SW Shares Outstanding |
| = | $661.74 | * | 72.14 M | |
| = | $47.74 B |